Saturday mornings is a time when we come together and talk beyond medicine…The great debate for 2026: Patient Experience Is a Better Measure of Health System Performance Than Clinical Outcomes. #TALES #Tatamedicalcenter #Morningcuppa
Arijit Nag retweeted
My latest post for @NEJMClinician: Azacitidine–Venetoclax or 7+3 Induction for AML -- 7+3 isn't quite dead yet! @SylvesterCancer @UMiamiHealth @ASH_hematology clinician.nejm.org/CLINjwNA6…
How do you get better as a physician…..words of wisdom from Prof. Gautam Biswas #tales #TataMedicalCenter #inspiration
Arijit Nag retweeted
Bone Marrow Harvests in the age of PBSCs
Let's dive into the world of bone marrow harvests, a vital procedure for obtaining hematopoietic stem cells for transplantation
An important alternative to peripheral blood stem cell collection in certain clinical situations.
This will be my first attempt at a🧵so kindly bear with my ineptitude 1/11
#BoneMarrowHarvest #bmtsm
Sunday morning read: The TOI has a column by Prof. Abhijeet Banerjee on Sundays. Its a pleasure reading. Highly recommend….
timesofindia.indiatimes.com/…
Arijit Nag retweeted
Thanks @AmarUjalaNews for highlighting this important message. Earlier BMT better outcome for thalassemia patients. BMT for thalassemia is supported by various government schemes including Coal India Project of @MoHFW_INDIA #ITD2024 @PIB_India
Arijit Nag retweeted
📢Announcing HCC's 11th Support Group Meeting themed "Survivorship" on April 20, 2024, 11:00 AM -12.00 PM IST. Please like & RT for the benefit of pts and caregivers in your network. Joining details below 👇
@TataMemorial Dr Maya Prasad
Sometimes it takes a universe to achieve a milestone. Cheers to our entire #hemeteam at @TMCKolkata. This is a testatment of the good work that has been done over the last decade. Proud of all that we achieved together. And it just keeps getting better….
First Indian BMT program accredited by #FACT ! Congrats to #TataMedicalCenter in Kolkata BMT team. 🙏 @Nadim_M_Chicago for supporting international accreditation in LMIC @APBMT_BCT @ASTCT
Arijit Nag retweeted
First Indian BMT program accredited by #FACT ! Congrats to #TataMedicalCenter in Kolkata BMT team. 🙏 @Nadim_M_Chicago for supporting international accreditation in LMIC @APBMT_BCT @ASTCT
Arijit Nag retweeted
Fundamentals of HCT training course with $15 USD registration rate for persons from LMICs.
Kudos to @ASTCT for this effort towards global equity in #BMTsm and #CARTcells education.
astct.org/Attend/Fundamental…
See y’all….
The largest meeting of bone marrow transplant and cell therpay in India. #ISBMT24
@ISBMT
@IsbmtU
Register using link below for exciting educational events.
Abstract presenters can get travel support. Check more on the website ⏬️
isbmt.org/isbmt-2024/reg…
Arijit Nag retweeted
The largest meeting of bone marrow transplant and cell therpay in India. #ISBMT24
@ISBMT
@IsbmtU
Register using link below for exciting educational events.
Abstract presenters can get travel support. Check more on the website ⏬️
isbmt.org/isbmt-2024/reg…
Arijit Nag retweeted
RT Transplant_Doc "RT BldCancerDoc: #BMTTandem18 late breaking abstracts: Dr Bolanos-Meade presents HopkinsMedicine data on use of NMA #BMT w/ #haplo donors and #PTxCy for #SickleCell and #thalassemia xitter.cf/BldCancerDoc/status/96…"
Arijit Nag retweeted
Clinical decision-making and treatment of myelodysplastic syndromes
loom.ly/8BvtqfA #myeloidneoplasia #reviewarticles #reviewseries
Arijit Nag retweeted
So amazing to see an Indian in this uber-powerful list
Ten people (and one non-human) who helped shape science in 2023 nature.com/immersive/d41586-…
Arijit Nag retweeted
📢Announcing HCC's 7th Support Group Meeting themed "Immunotherapy as Treatment Option of Blood Cancer" on December 16, 2023, 11:00 AM -12.00 PM IST
Please like & RT for the benefit of pts and caregivers in your network. Joining details below 👇
The biggest challenge of HSCTs in our part of the globe continues to be MDRO bugs. We highlight this in our latest paper. This is a call for action. We need to do better.
onlinelibrary.wiley.com/doi/…
